🇺🇸 FDA
Pipeline program

Bronchial basal cells

20170206

Phase 2 mab completed

Quick answer

Bronchial basal cells for Chronic Obstructive Pulmonary Disease is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Chronic Obstructive Pulmonary Disease
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials